Minocycline

3 trials 3 recruiting JAnti-infectives

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

3 Recruiting

0 Completed trials

3 Sponsors

2 Countries

Phase III

Phase IV

Phase III: 2 Phase IV: 1

Oversight events:

1 serious breach across 1 trial

View oversight register →

Sponsors using this IMP

Leiden University Medical Center 1 Universitair Medisch Centrum Utrecht 1 University Of Antwerp 1

All trials

3 total

RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Recruiting

2024-511580-28-02 Phase III 1 country Universitair Medisch Centrum Utrecht
INSTA-MD: INflammation-based Stratification for immune-Targeted Augmentation in Major Depressive disorder Recruiting

2022-501692-35-00 Phase III 1 country University Of Antwerp
The RiCOTTA study: Rifampicin Combination Therapy versus Targeted Antibiotic Monotherapy for Infected Joint Prostheses Caused by Staphylococ… Recruiting

2022-501620-26-00 Phase IV 1 country Leiden University Medical Center

Showing 1–3 of 3 trials

← All drugs A–Z